Plimoth Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $923K | Hold |
6,625
| – | – | 0.21% | 94 |
|
|
2025
Q4 | $813K | Hold |
6,625
| – | – | 0.18% | 97 |
|
|
2025
Q3 | $735K | Sell |
6,625
-370
| -5% | -$42.1K | 0.17% | 104 |
|
|
2025
Q2 | $776K | Hold |
6,995
| – | – | 0.19% | 101 |
|
|
2025
Q1 | $784K | Sell |
6,995
-170
| -2% | -$17.5K | 0.2% | 100 |
|
|
2024
Q4 | $662K | Sell |
7,165
-200
| -3% | -$18K | 0.17% | 103 |
|
|
2024
Q3 | $617K | Sell |
7,365
-50
| -0.7% | -$3.81K | 0.16% | 113 |
|
|
2024
Q2 | $509K | Sell |
7,415
-370
| -5% | -$24.7K | 0.14% | 113 |
|
|
2024
Q1 | $570K | Sell |
7,785
-1,455
| -16% | -$112K | 0.15% | 110 |
|
|
2023
Q4 | $749K | Sell |
9,240
-10
| -0.1% | -$778 | 0.22% | 100 |
|
|
2023
Q3 | $693K | Hold |
9,250
| – | – | 0.22% | 101 |
|
|
2023
Q2 | $713K | Sell |
9,250
-50
| -0.5% | -$3.99K | 0.21% | 103 |
|
|
2023
Q1 | $772K | Sell |
9,300
-175
| -2% | -$14.5K | 0.24% | 98 |
|
|
2022
Q4 | $814K | Sell |
9,475
-235
| -2% | -$18.6K | 0.26% | 98 |
|
|
2022
Q3 | $600K | Sell |
9,710
-100
| -1% | -$6.31K | 0.21% | 115 |
|
|
2022
Q2 | $607K | Buy |
9,810
+65
| +0.7% | +$4.02K | 0.19% | 120 |
|
|
2022
Q1 | $580K | Sell |
9,745
-360
| -4% | -$23K | 0.15% | 123 |
|
|
2021
Q4 | $734K | Sell |
10,105
-400
| -4% | -$27.6K | 0.19% | 117 |
|
|
2021
Q3 | $734K | Sell |
10,505
-747
| -7% | -$52.5K | 0.21% | 112 |
|
|
2021
Q2 | $775K | Sell |
11,252
-3,555
| -24% | -$237K | 0.22% | 107 |
|
|
2021
Q1 | $957K | Sell |
14,807
-2,054
| -12% | -$132K | 0.28% | 93 |
|
|
2020
Q4 | $982K | Sell |
16,861
-5,260
| -24% | -$317K | 0.31% | 83 |
|
|
2020
Q3 | $1.4M | Sell |
22,121
-6,677
| -23% | -$463K | 0.47% | 66 |
|
|
2020
Q2 | $2.22M | Sell |
28,798
-2,199
| -7% | -$169K | 0.79% | 42 |
|
|
2020
Q1 | $2.32M | Sell |
30,997
-957
| -3% | -$66.1K | 0.97% | 31 |
|
|
2019
Q4 | $2.08M | Sell |
31,954
-1,058
| -3% | -$68.9K | 0.67% | 47 |
|
|
2019
Q3 | $2.09M | Sell |
33,012
-9,349
| -22% | -$611K | 0.69% | 43 |
|
|
2019
Q2 | $2.86M | Sell |
42,361
-2,415
| -5% | -$159K | 0.94% | 30 |
|
|
2019
Q1 | $2.91M | Buy |
44,776
+245
| +0.6% | +$16.3K | 0.97% | 26 |
|
|
2018
Q4 | $2.79M | Buy |
44,531
+675
| +2% | +$47.2K | 1.03% | 25 |
|
|
2018
Q3 | $3.39M | Buy |
43,856
+365
| +0.8% | +$27.6K | 1.1% | 24 |
|
|
2018
Q2 | $3.08M | Buy |
43,491
+2,455
| +6% | +$173K | 1.06% | 25 |
|
|
2018
Q1 | $3.09M | Buy |
41,036
+2,914
| +8% | +$232K | 1.07% | 24 |
|
|
2017
Q4 | $2.73M | Buy |
+38,122
| New | +$2.89M | 0.98% | 27 |
|
Other funds holding GILD
VCM
VPM
Plimoth Trust's GILD Position: Q1 2026 in Review
Plimoth Trust held its Gilead Sciences (GILD) position steady in Q1 2026 at 6,625 shares worth $923K. The position accounts for 0.21% of the portfolio, ranked #94.
Plimoth Trust first reported a position in GILD in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.39M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Plimoth Trust held 6,625 shares of Gilead Sciences worth $923K as of Q1 2026.
- Plimoth Trust left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.21% of Plimoth Trust's portfolio in Q1 2026, its #94 holding.
- Plimoth Trust first reported a position in Gilead Sciences in Q4 2017 and has held it in 34 quarters since.
- Plimoth Trust's Gilead Sciences position peaked at $3.39M in Q3 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Plimoth Trust's 13F filing for Q1 2026, filed 27 Apr 2026.